Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 May 9;30(5):239–244. doi: 10.1002/clc.20078

Characteristics and in‐hospital mortality of diabetics and nondiabetics with an Acute Coronary Syndrome; the GREECS study

Christos Pitsavos, 1, Georgia Kourlaba, 1,✉, Demosthenes B Panagiotakos, 2, Christodoulos Stefanadis, 1
PMCID: PMC6653390  PMID: 17492678

Abstract

Objectives

In this work, we sought to describe the baseline characteristics and the management of patients with and without diabetes hospitalized with acute coronary syndromes (ACS), as well as to assess the prognostic value of diabetes status to the severity of ACS and in‐hospital mortality.

Methods

A sample of six hospitals located in Greek urban and rural regions was selected and we recorded almost all admissions due to ACS, from October 2003 to September 2004. 2,172 patients were included in the study. Socio‐demographic, clinical, dietary and other lifestyle characteristics was recorded.

Results

Approximately 1 in 3 patients admitted at the hospital with ACS had history of diabetes. Diabetes mellitus was associated with old age, female gender and more prevalent history of coronary heart disease, hypertension and renal failure. Diabetics sought medical care later and they were less likely to receive fibrinolytic therapy. No statistically significant difference was observed on severity of ACS between diabetics and nondiabetics. The in‐hospital mortality was higher in diabetics compared to nondiabetics. In a multivariate analysis only insulin‐treated diabetics had an increased mortality rate compared to nondiabetics.

Conclusions

The use of more effective medications and interventions must be used in diabetics who develop ACS, as well as educational efforts should be directed to those patients for reducing the pre‐hospital delay. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: diabetes mellitus, acute coronary syn dromes, in‐hospital mortality, antidiabetic treatment

Full Text

The Full Text of this article is available as a PDF (422.1 KB).

References

  • 1. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, et al.: Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998; 21: 69–75. [DOI] [PubMed] [Google Scholar]
  • 2. Galcerá‐Tomás J, Melgarejo‐Moreno A, Garcia‐Alberola A, Rodriguez‐Garcia P, Lozano‐Martinez J, et al.: Prognostic significance of diabetes in acute myocardial infarction: are the differences linked to female gender? Int J Cardiol 1999; 69: 289–298. [DOI] [PubMed] [Google Scholar]
  • 3. Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL: Myocardial infarct size and mortality in diabetic patients. Br Heart J 1985; 54(4): 466–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lehto S, Pyorala K, Miettinen H, Ronnemaa T, Palomaki P, et al.: Myocardial infarct size and mortality in patients with non‐insulin‐dependent diabetes mellitus. J Intern Med 1994; 236: 291–297. [DOI] [PubMed] [Google Scholar]
  • 5. Granger CB, Califf RM, Young S, Candela R, Samaha J, et al.: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993; 21(4): 920–925. [DOI] [PubMed] [Google Scholar]
  • 6. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, et al., Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO)‐1 Investigators: Influence of diabetes mellitus on clinical outcome in the thrombolytic area of acute myocardial infarction. J Am Coll Cardiol 1997; 30: 171–179. [DOI] [PubMed] [Google Scholar]
  • 7. Fava S, Azzorpadi J, Agius‐Muscat H: Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 1997; 14: 209–213. [DOI] [PubMed] [Google Scholar]
  • 8. Malmberg K, Yusuf S, Gerstein H, Brown J, Zhao F, et al., OASIS Registry Investigators: Impact of diabetes on long‐term prognosis in patients with anstable angina and non‐Q‐wave myocardial infarction: results of the OASIS Registry. Circulation 2000; 102: 1014–1019. [DOI] [PubMed] [Google Scholar]
  • 9. Gowda MS, Vacek JL, Hallas D: One‐year outcomes of diabetic versus nondiabetic patients with non‐Q‐wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 1998; 81: 1067–1071. [DOI] [PubMed] [Google Scholar]
  • 10. McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, et al., GUSTO‐IIb Investigators. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes, Findings from the GUSTO‐IIb Study. Eur Heart J 2000; 21: 750–1758. [DOI] [PubMed] [Google Scholar]
  • 11. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, et al., GRACE Investigators: Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004; 164: 1457–1463. [DOI] [PubMed] [Google Scholar]
  • 12. Hasdai D, Behar S, Boyko V, Battler A: Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes. Coron Artery Dis 2004; 15: 129–135. [DOI] [PubMed] [Google Scholar]
  • 13. Pitsavos C, Panagiotakos DB, Antonoulas A, Zombolos S, Kogias Y, et al., Greek Study of Acute Coronary Syndromes Study Investigators. Epidemiology of acute coronary syndromes in a Mediterranean country; aims, design and baseline characteristics of the Greek study of acute coronary syndromes (GREECS). BMC Public Health 2005; 5: 23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 502–1513. [DOI] [PubMed] [Google Scholar]
  • 15. Braunwald E: Heart Disease (5th ed.) London: W.B. Saunders Company; 1997. [Google Scholar]
  • 16. Marchant B, Umachandran V, Stevenson R, Kopelman P, Timmis A: Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993; 22: 1433–1437. [DOI] [PubMed] [Google Scholar]
  • 17.Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343: 311–322. [PubMed] [Google Scholar]
  • 18. Hansen HH, Kjaergaard SC, Bulöw I, Fog L, Christensen PD: Thrombolytic therapy in diabetic patients with acute myocardial infarction. Diabetes Care 1996; 19: 1135–1137. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES